Perspectives on the Use of Comparative Effectiveness Research by Life Sciences Executives: An Interview with Mike Bonney

Mr. Michael W. Bonney, B.A., Partner at Third Rock Ventures, LLC and former CEO of Cubist Pharmaceuticals Inc., discusses his personal experience with using comparative effectiveness research in decision making while presiding over Cubist. He also considers how the introduction of the Affordable Care Act and increasing interest in the budget impact of the pricing of recent pharmaceuticals are changing health care decision making and impacting manufacturer decision making.